Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Technische Universität Dresden

Clinical trials sponsored by Technische Universität Dresden, explained in plain language.

Trials to join now! 10 Not yet recruiting 2 Not yet finished but already full! 1 Completed 1

Immunotherapy-Chemo combo trial aims to extend lives in Tough-to-Treat lung cancer

Disease control Ongoing

This study is testing whether adding the immunotherapy drug atezolizumab to standard chemotherapy helps people with advanced large-cell neuroendocrine lung cancer live longer. It involves 67 adults with this specific cancer who haven't had prior treatment for their advanced disea…

Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC